INVASIVE DUCTAL BREAST CARCINOMA
Clinical trials for INVASIVE DUCTAL BREAST CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new INVASIVE DUCTAL BREAST CARCINOMA trials appear
Sign up with your email to follow new studies for INVASIVE DUCTAL BREAST CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cold sore virus turned cancer assassin shows promise in tough breast cancer
Disease control CompletedThis study tested whether injecting a modified herpes virus (T-VEC) directly into tumors, alongside standard chemotherapy before surgery, could better eliminate triple negative breast cancer. The virus is designed to infect and destroy cancer cells while leaving healthy cells alo…
Matched conditions: INVASIVE DUCTAL BREAST CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 16, 2026 12:54 UTC
-
Breakthrough fertility method may keep estrogen low during cancer treatment
Disease control CompletedThis study tested a new ovarian stimulation protocol using degarelix (a drug typically used for prostate cancer) to help breast cancer patients preserve their fertility before chemotherapy. The goal was to keep estrogen levels low while still collecting enough eggs for freezing. …
Matched conditions: INVASIVE DUCTAL BREAST CARCINOMA
Phase: PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 15, 2026 19:05 UTC
-
Shrinking tumors before surgery: a gentler approach for early breast cancer?
Symptom relief CompletedThis pilot study tested whether giving a high dose of focused radiation to the tumor before surgery is feasible for older patients with early-stage, hormone-sensitive breast cancer. The goal was to shrink the tumor and reduce the amount of healthy tissue removed during surgery. T…
Matched conditions: INVASIVE DUCTAL BREAST CARCINOMA
Phase: NA • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Symptom relief
Last updated Jun 15, 2026 18:57 UTC